Blog - Page 5 of 20 - TriNetX

TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

Cambridge, MA, January 31, 2024 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, is proud to announce its participation in the CERTAINTY project. CERTAINTY, short for CEllulaR...
TriNetX Appoints Jason Meggs as Chief Financial Officer

TriNetX Appoints Jason Meggs as Chief Financial Officer

Cambridge, MA, July 5, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Jason Meggs has joined the company as Chief Financial Officer. “I am pleased to...
Natural Allies: TriNetX and the CTTI

Natural Allies: TriNetX and the CTTI

What’s more effective than working in parallel? Working together. Since our founding in 2013, TriNetX has delivered the data, technology, and services crucial to making trials “real-world ready”. We were never alone in that pursuit. Since 2007, the Clinical Trials...